Arcoma AB (ARCOMA.ST) Stock Analysis & Winston Score
Arcoma AB is a Swedish company that makes X-ray imaging systems used in hospitals and clinics. Its core products are digital radiography rooms — the large machines that take X-ray pictures of patients — sold mainly to healthcare providers across Europe. The company has been building medical imaging equipment for decades and focuses specifically on fixed, room-based X-ray systems rather than portable devices. Arcoma earns money by selling its imaging systems directly to hospitals and through distribution partners, with additional revenue from service contracts and spare parts. It operates primarily in Europe, with Sweden as its home base, and generates roughly $50–60 million in annual revenue, making it a small player in the global medical imaging market dominated by much larger companies like Siemens and Philips. Its main competitive challenge is competing on price and technology against those giants, while its growth opportunity lies in hospital equipment upgrade cycles and expanding its distributor network into new European markets.
Winston Score: 40/100 — Average
Mixed quality — meaningful strengths and weaknesses.
- Quality: Weak (6/30)
- Growth: Weak (2/20)
- Cash Flow: Strong (8/10)
- Stability: Good (5/10)
- Valuation: Strong (7/10)
- Ownership: Good (10/15)
Key Facts
Price: 8.10 SEK
Market Cap: 116M SEK
Sector: Healthcare
Industry: Medical - Devices
Exchange: Stockholm Stock Exchange


